In this guide
What is the skin and hair stack?
The skin and hair stack is GHK-Cu, a copper peptide, used with KPV for red or inflamed skin, or with SNAP-8 for expression lines. It is sold premixed as Beauty Blend (GHK-Cu and KPV), GLOW and KLOW. People hope for firmer skin and thicker hair. No study has tested these peptides together in people. [4], [2], [1]
On the skin, GHK-Cu and SNAP-8 share one serum. By injection, GHK-Cu and KPV come as separate vials, as Beauty Blend, or inside GLOW and KLOW, which add the healing peptides BPC-157 and TB-500. [14], [15]
Only GHK-Cu has human skin studies, all of creams and serums. KPV has never been given to people in a study, and SNAP-8 has only been tested inside multi-ingredient products. Each part has its own guide, linked above. [5], [6], [16]
A premix locks the ratio: with the common Beauty Blend, every 2 mg of GHK-Cu brings 800 mcg of KPV, more than KPV's usual 200–500 mcg. For athletes, injected KPV and GHK-Cu likely fall under WADA's ban on unapproved substances. [2], [17], [18]
What's in it, and what else is it called?
The core is GHK-Cu. KPV is its usual injected partner and SNAP-8 its usual partner in serums. GLOW and KLOW also contain BPC-157 and TB-500. [12], [1]
| Name | Type | What it usually contains | Where sources disagree |
|---|---|---|---|
| KLOW | Premixed blend | GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg per vial (80 mg in total) [1], [8] | Sold for joints and skin. One 60 mg "Klow" has no KPV, and one seller sells the 80 mg formula as "Glow Plus". [9], [10] KLOW details |
| GLOW | Premixed blend | GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg per vial (70 mg in total) [1] | Sold mainly for skin. Other vials hold less GHK-Cu, and one lists full thymosin beta-4 instead of TB-500. [11] GLOW details |
| Beauty Blend | Premixed blend | GHK-Cu 50 mg + KPV 20 mg per vial (70 mg in total) at most sellers [2], [12] | Often sold without the name, as "GHK-Cu + KPV". Some vials hold KPV 10 mg (60 mg in total), half as much. [3], [13] Beauty Blend details |
A name does not fix what is in the vial. One seller sells the KLOW formula as "Glow Plus", another uses "Klow Stack" for GHK-Cu and KPV alone, and the KPV amount differs between vials of the same name (10 or 20 mg). Only the label's amount for each peptide tells you what a dose contains. [10], [3], [19]
What is in each blend in this stack?
Three premixed blends carry this stack. KLOW and GLOW are the most common; their full details are in the healing and recovery stack. Beauty Blend is GHK-Cu and KPV alone. No blend has been tested in people.
Amounts are what labels print, not doses, and labels are not proof: in consumer-submitted tests, some research peptide samples lacked the stated peptide. [20]
KLOW
GHK-Cu with BPC-157, TB-500 and KPV. In the 80 mg vial, 1 mg of powder holds 625 mcg of GHK-Cu and 125 mcg of each other part. Full KLOW details
| Vial | GHK-Cu | BPC-157 | TB-500 | KPV | Sources |
|---|---|---|---|---|---|
| 80 mg (most common) | 50 mg | 10 mg | 10 mg | 10 mg | [1], [8] |
| 60 mg ("Klow", one EU seller) | 50 mg | 5 mg | 5 mg | None | [9] |
- Where sellers disagree: one 60 mg "Klow" has no KPV, one seller sells the 80 mg formula as "Glow Plus", and a protocol site calls it the "Deadpool Stack", a name other sellers use for BPC-157 and TB-500 with Cartalax. [10], [21]
- For skin: protocol pages position it for eczema, psoriasis and rosacea, while noting that no clinical study has tested it for any skin condition. [15]
- What the extra parts add: BPC-157 and TB-500 are healing peptides with no skin or hair study in people, and KPV has no human study of any kind. [22], [6] KLOW's gut use is covered in the gut stack.
- Stated amounts and regulators: one page gives a skin-flare schedule (see combination schedules); Health Canada named KLOW 80 mg in a 2025 seizure notice. [15], [1]
GLOW
KLOW without KPV, sold mainly for skin. In the 70 mg vial, 1 mg of powder holds about 714 mcg of GHK-Cu and 143 mcg each of BPC-157 and TB-500. Full GLOW details
| Vial | GHK-Cu | BPC-157 | TB-500 | Sources |
|---|---|---|---|---|
| 30 mg | 20 mg | 5 mg | 5 mg | [23] |
| 50 mg | 30 mg | 10 mg | 10 mg | [11] |
| 60 mg | 40 mg | 10 mg | 10 mg | [24] |
| 70 mg (most common) | 50 mg | 10 mg | 10 mg | [1], [25] |
- Where sellers disagree: on the GHK-Cu amount, so the same dose of powder carries different amounts of each part, and on the TB part: one seller lists full-length thymosin beta-4, not the TB-500 fragment. [23], [11]
- What the extra parts add: the same healing peptides as KLOW, with no skin evidence in people; both are banned in sport by name. [18]
- Stated amounts and regulators: about 2.33 mg of powder daily on one protocol page (see combination schedules); Health Canada named GLOW 70 mg in the same notice. [25], [1]
Beauty Blend (GHK-Cu and KPV)
GHK-Cu and KPV in one vial. We found it at six sellers; only two use the name "Beauty Blend".
| Vial | GHK-Cu | KPV | GHK-Cu to KPV | Sources |
|---|---|---|---|---|
| 70 mg (most common) | 50 mg | 20 mg | 5 : 2 | [2], [12], [19], [26] |
| 60 mg | 50 mg | 10 mg | 5 : 1 | [3], [13] |
- Where sellers disagree: the KPV amount doubles between versions, and one seller calls the 60 mg vial a "Klow Stack". [3]
- What KPV is claimed to add: calmer eczema, rosacea and redness. KPV's guide finds no human studies, only mouse and skin-cell work. [27], [28] KPV sold for the gut is covered in the gut stack.
- Seller-stated amounts: none of the six pages gives a schedule, and we found no published one elsewhere.
- Regulators: no notice we found names Beauty Blend. Health Canada has seized GHK-Cu and KPV as separate products. [29]
- Related stacks: KLOW and GLOW in the healing and recovery stack.
Other names you may see
Single sellers add other peptides to "beauty" vials. "AURA" lists GHK-Cu 70 mg with Epithalon, SNAP-8 and KPV at 10 mg each; "Pro Beauty Blend" adds BPC-157, TB-500, CJC (the label does not say which form) and ipamorelin to GHK-Cu and KPV; and a hair-marketed vial pairs GHK-Cu with AHK-Cu, a different copper peptide that has no Doserly guide. [30] Epithalon courses are covered in the bioregulator courses stack, and CJC with ipamorelin in the CJC-1295 and ipamorelin stack., [31], [32] A "KLOWS-8" vial adds SNAP-8 to KLOW (115 mg), but its public page does not list the amount of each part, so we do not print one. [33]
Why do people combine GHK-Cu with KPV or SNAP-8?
People combine them hoping each part covers a different skin problem. That is a rationale built from separate studies of each part, not proof that they work together. [15], [14]
- Different jobs. Protocol and seller pages cast GHK-Cu for collagen and texture, KPV for redness and SNAP-8 for lines where the face moves. [15], [3], [14]
- One step. A premix or two-peptide serum replaces two. [14]
- Less sting. In community education groups, some add KPV hoping it eases GHK-Cu injection burning. Reports go both ways; nobody has tested it.
- A better serum. In the same groups, most SNAP-8 users mix it with GHK-Cu, believing the copper peptide helps. That is untested too.
What does the evidence show?
No study has tested any version of this stack as a combination in people, and each part has little human evidence on its own.
GHK-Cu
Human studies used creams and serums. In a company-connected 2016 study, wrinkle volume fell 55.8% more with a GHK-Cu serum than an inactive one over 8 weeks; a 2% eyebrow serum gave 30.5 hairs versus 28.7 after 12 weeks. A 2026 review found only 2 randomized human trials. Injected GHK-Cu has not been studied, and FDA flags a possible immune-reaction risk. [34], [35], [5], [36] Full GHK-Cu evidence
KPV
No human studies by any route, FDA found. For skin, a related peptide reduced ear swelling in mice and KPV calmed skin cells in a dish; the only human claims are patent examples. KPV does not measurably cross intact skin without a device. [6], [27], [28], [37], [38] Full KPV evidence
SNAP-8
Every human study used a multi-ingredient product, only one had a comparison group, and most were company-run. The famous "up to 63%" is the best single result in an unpublished 17-woman supplier test; the average was about 35%. Injected SNAP-8 has never been studied. [7], [16], [39] Full SNAP-8 evidence
The combination
- One rat study of a product containing GHK-Cu and SNAP-8, 2025. 18 rats with skin cuts were left untreated or injected with a product of about 20 ingredients, including both peptides. Treated wounds had thicker new skin and more collagen at day 14, but with no single-peptide or inactive-injection groups, the result cannot be credited to either peptide. [4]
- Hair. GHK-Cu has been tested for scalp hair only inside multi-ingredient products. The largest was a company-funded trial in 160 people with alopecia areata (patchy hair loss): a gel with GHK-Cu, three other peptides, postbiotics and a plant extract improved the hair-loss score by 69.56% versus 27.63% with placebo over 3 months. None contained KPV or SNAP-8. [40]
- Nothing else. We found no study of GHK-Cu with KPV in any species, no study of KPV with SNAP-8, no registered trial, and no study of Beauty Blend, GLOW or KLOW. [41]
How do the skin and hair stack protocols line up?
| Part | Amount each time | Frequency | Total per day or week | Duration | Source |
|---|---|---|---|---|---|
| GHK-Cu, injected | 1–2 mg | Once daily | 1–2 mg a day | About 30 days to 6 weeks, then 2–4 weeks off | [42], [43] |
| GHK-Cu, on the skin | 2% serum | Twice daily | Not applicable | 12 weeks (eyebrow trial) | [35] |
| KPV, injected | 200–500 mcg | Once daily | 200–500 mcg a day | About 4–8 weeks | [17] |
| SNAP-8, on the skin | Cream or serum with 3–10% of the supplier's solution (about 0.0015–0.005% SNAP-8) | Twice daily | Not applicable | Judge the result at about 4 weeks | [7], [44], [45] |
| SNAP-8, injected | Not established | Not established | Not established | Never studied | [7] |
These are each part's most common protocol from its own guide, not a stack protocol. [6], [7]
Schedules published for the combination
Each row is one page's complete schedule, not a tested dose. We found none for Beauty Blend or GHK-Cu with KPV alone.
| Format | Per dose | Frequency | Duration | Source |
|---|---|---|---|---|
| Ready-made serum, GHK-Cu 2% + SNAP-8 0.02%, on the skin | 2 drops | Twice daily | About 8 weeks to the claimed effect; no end date | [14] |
| GLOW 70 mg, injected | About 1.67 mg GHK-Cu + about 333 mcg each of BPC-157 and TB-500 (2.33 mg of blend) | Once daily | 4–8 weeks | [25] |
| KLOW 80 mg, skin-flare schedule, injected | GHK-Cu 1.25–2.5 mg + 250–500 mcg each of BPC-157, TB-500 and KPV | Daily for 2–4 weeks, then 3 times a week | Then 4–8 weeks | [15] |
| KLOW 80 mg, stepped, injected | GHK-Cu 1.25, 2.5, 3.75, then 2.5 mg, with 250, 500, 750, then 500 mcg of each other part | Daily | Weeks 1–2, 3–4, 5–8 and 9–12 | [46] |
| KLOW parts as four separate vials, injected | GHK-Cu 1–2 mg; KPV 0.5–2 mg; BPC-157 300–600 mcg; TB-500 2 mg | GHK-Cu and BPC-157 daily; KPV once or twice daily; TB-500 twice a week | 4–8 weeks | [47] |
The serum's 0.02% SNAP-8 is about 4 to 13 times the supplier's tested level. [14], [7]
What each blend delivers
Arithmetic from each vial's listed amounts, not a dose.
| Blend (vial) | In 1 mg of blend | Alongside 2 mg of GHK-Cu | Source |
|---|---|---|---|
| Beauty Blend 50/20 (70 mg) | About 714 mcg GHK-Cu + 286 mcg KPV | 800 mcg KPV (2.8 mg of blend) | [2] |
| Beauty Blend 50/10 (60 mg) | About 833 mcg GHK-Cu + 167 mcg KPV | 400 mcg KPV (2.4 mg of blend) | [3] |
| GLOW (70 mg) | About 714 mcg GHK-Cu + 143 mcg each of BPC-157 and TB-500 | 400 mcg each of BPC-157 and TB-500 | [1] |
| KLOW (80 mg) | 625 mcg GHK-Cu + 125 mcg each of BPC-157, TB-500 and KPV | 400 mcg each of BPC-157, TB-500 and KPV | [1] |
How people line them up
Sources describe three styles, and nobody has compared them: one premixed vial a day dosed by its GHK-Cu amount, separate vials on their own schedules, or an injected blend plus a GHK-Cu serum. One protocol page notes that a "KLOW" cream acts only as a GHK-Cu cream, because the other parts do not get through the skin. [15], [47], [38]
In community education groups, injected users commonly start from GHK-Cu at about 2 mg a day plus KPV at 250–500 mcg, and serum users mix SNAP-8 with GHK-Cu in hyaluronic-acid serum, usually far above the supplier's strength, as public forum recipes also show. [48], [7]
These schedules come from protocol sources for each part; no trial has tested this combination.
Where these numbers come from
The first table copies each part's most common protocol from its Doserly guide, citing the original protocol pages and the eyebrow trial those guides verified. The combination schedules each come from one page and are shown as published, not merged. The blend table is arithmetic from listed vial contents. We did not combine one page's GHK-Cu amount with another page's KPV amount, and we did not scale animal doses to people. [42], [17], [7], [15], [14], [46]
Plan it once. A daily injection, a twice-daily serum and planned breaks are easy to lose track of.
What are the overlapping risks and interactions?
No part has been safety-tested in people when injected, and the combination never has. The shared risks are reactions that cannot be traced inside a blend, copper, and vials that do not match the label. [36], [6]
- Allergic and injection reactions add up. FDA raised immune reactions as a concern for injected GHK-Cu and found no safety studies for KPV; each extra peptide is another chance for a reaction. [36], [6] In community education groups, burning and welts on blends are usually blamed on GHK-Cu, unconfirmed.
- Side effects cannot be traced. FDA could not say which peptide caused a reaction to a two-peptide product. [22]
- SNAP-8 by injection is unknown. It is a cosmetic ingredient, not a sterile injectable, and has never been studied injected, yet some sellers add it to vials sold alongside injectable blends such as KLOW. [7], [33]
- Serums. Several actives in one serum can add up to redness and dryness, so patch-test one new product at a time. [49], [39] With microneedling, topical serums (mostly vitamin C products) have caused skin lumps called granulomas, and homemade serums are not sterile. [50], [51]
- Copper. About 16% of GHK-Cu's weight is copper, so 2 mg carries about 0.32 mg, which matters with Wilson disease (a copper build-up condition) or copper supplements. [52], [53]
- Blood vessels and tumours (theoretical). Copper-bound GHK triggered new blood-vessel growth in rabbits, and GLOW and KLOW add BPC-157 (blood-vessel growth in animals) and TB-500 (thymosin beta-4 helps tumours grow in some animal models). There are no human data. [54], [22], [55]
- Product quality. An injectable GHK-Cu product was recalled over sterility. [56] In community education groups, a home-mixed vial of several peptides turned dark within days.
Interactions. No interaction between these peptides, or with retinoids, minoxidil, finasteride or botulinum toxin, has been studied; that is an absence of data, not evidence of safety. Do not stop prescribed skin treatment, such as dupilumab, to try KPV or a blend. [6]
Be especially cautious or avoid them in pregnancy, breastfeeding or when trying to conceive; under 18; with a current or past cancer (see blood vessels and tumours above); with Wilson disease; with past allergic reactions or hives; on immune-suppressing treatment; with facial muscle weakness (SNAP-8); and in competitive sport (any injected part; GLOW and KLOW are named bans).
Legal and sport status (checked September 2026):
- United States: no part is an FDA-approved medicine. For KPV in pharmacy compounding, FDA staff advised against and an advisory committee voted in favour in July 2026; no final rule has followed. Injectable GHK-Cu is a withdrawn nomination with an immune-reaction concern; the non-injectable form goes to the committee by February 2027. SNAP-8 is sold as a cosmetic ingredient. [6], [57], [36], [58], [7]
- Canada: Health Canada says injectable peptides are regulated as prescription drugs and lists GHK-Cu and KPV among peptides sold illegally; a 2025 seizure notice named GLOW and KLOW. SNAP-8 is not on its restricted cosmetic ingredient list. [59], [60], [1], [61]
- Australia: the TGA names GHK-Cu among unapproved peptide products. KPV and SNAP-8 have no entry in the June 2026 Poisons Standard. [62], [63]
- New Zealand and EU: Medsafe has proposed making injectable GHK-Cu prescription-only (meeting 28 October 2026), and the EU lists SNAP-8 as a cosmetic ingredient with no restrictions. [64], [65]
- Sport: WADA's 2026 list does not name GHK-Cu, KPV or SNAP-8, but its S0 class bans substances not approved for human use. Injected KPV and GHK-Cu are likely covered by S0, so athletes should treat Beauty Blend and the separate injections as banned too. USADA lists plain GHK in cosmetics as not prohibited, but that does not address injected GHK-Cu. GLOW and KLOW contain BPC-157 and TB-500, banned at all times. [18], [66]
What should be monitored?
No official monitoring guidance exists. What studies of the parts measured or flagged:
- Skin: wrinkles, texture and redness, as the studies measured them, from consistent photos in the same light. [34], [16]
- Hair: hair counts or photos at fixed angles, noting any change to minoxidil, finasteride or diet. [35], [40]
- Reactions: injection-site pain, welts, rashes and hives; with a serum, redness and dryness. [36] In community education groups, facial drooping has been described with very strong SNAP-8 serums.
- Blood work: no study has measured copper after GHK-Cu injections; the NIH copper fact sheet explains why extra copper matters with Wilson disease. The 1994 wound-gel trial collected liver tests and blood copper but did not report them. [67], [53] With GLOW or KLOW, see the kidney, liver, blood-count and clotting checks in the healing and recovery stack.
With a blend, a reaction cannot be traced to one part. Stop and talk to a clinician before restarting anything. [22]
What happens when you stop?
Stopping has not been studied for any part, and nobody has studied stopping one part while continuing another. The skin and eyebrow trials stopped measuring at their last visit. [35], [34], [16]
- Benefits that faded. In a public forum, one person said facial redness slowly returned during a month off GHK-Cu injections. [68]
- Benefits that lasted. Another said hand eczema had not returned nearly three weeks after stopping KPV. [69]
- Community accounts. In community education groups, one person had a bad breakout about 10 days after stopping GHK-Cu and KPV together; the cause is unknown.
Premixed blend or separate vials?
A premix or two-peptide serum is simpler, but it fixes the ratio, hides which part caused a reaction and has never been stability-tested. Separate vials and bottles keep each dose adjustable and traceable.
- Mixing and stability. No published study shows whether GHK-Cu stays stable mixed with KPV or SNAP-8 in a vial, syringe or serum. GHK-Cu itself breaks down faster in alkaline or oxidising conditions. Copper can cut some peptides that contain histidine under harsh lab conditions, but neither KPV nor SNAP-8 contains histidine, so the common claim that copper "inactivates" SNAP-8 is untested either way. [70], [71]
- The ratio is locked. With a 50/20 Beauty Blend, 2 mg of GHK-Cu comes with 800 mcg of KPV, above KPV's usual 200–500 mcg. To get 500 mcg of KPV you take 1.25 mg of GHK-Cu. If GHK-Cu stings and you halve the dose, you also halve the KPV. [2], [17]
- Tracking and troubleshooting. With separate vials or bottles, a reaction can be narrowed down to one part. With a blend, it cannot. [22]
- Route. A blend fixes one route for parts that suit different ones: KPV barely crosses skin without a device, and SNAP-8 has never been studied injected. [38], [7]
- Units. Blend doses weigh the whole powder: 2.8 mg of a 50/20 Beauty Blend is 2 mg of GHK-Cu and 800 mcg of KPV. Work out syringe units for your own vial with the reconstitution calculator. [19], [13]
Common questions about the skin and hair stack
What is Beauty Blend?
A premixed vial of GHK-Cu and KPV, usually 50 mg and 20 mg. Some vials hold 10 mg of KPV instead, and most sellers list the formula without the name. No seller page we checked gives a dosing schedule, and it has not been tested in people. [2], [3]
What is the difference between Beauty Blend, GLOW and KLOW?
All three are mostly GHK-Cu. Beauty Blend adds only KPV; GLOW adds BPC-157 and TB-500; KLOW adds all three. The healing peptides bring no skin evidence in people and are banned in sport by name. Injected KPV and GHK-Cu likely fall under WADA's ban on unapproved substances too, so athletes should treat all three blends as banned. [1], [18]
Can you mix GHK-Cu and SNAP-8 in one serum?
People do, and ready-made serums combine them, but nobody has tested whether the mix stays stable. The claim that copper "inactivates" SNAP-8 has no test behind it either way. Keeping two bottles makes a reaction easier to trace. [14], [71]
Can you inject SNAP-8?
It has never been studied by injection, so there is no established dose. It is a cosmetic ingredient meant to act where applied, not a sterile injectable. [7]
Does this stack regrow hair?
It has not been shown to. The only controlled study of GHK-Cu alone found slightly more eyebrow hairs, and scalp trials tested it only inside multi-ingredient products. None tested KPV or SNAP-8 for hair. [35], [40]
How this guide was researched
How this guide was made
This stack guide was built from the verified sources of the GHK-Cu, KPV and SNAP-8 guides and the healing and recovery stack, re-citing the original documents rather than those guides. New research covered only what the combination raises: studies of the parts together, blend names and contents, mixing and stability, and regulator notices naming blends. Community education groups informed the descriptions of how people use the stack; no private post is quoted or linked.
The research file holds 158 records, 146 verified against the original page; this guide cites 71. Seller pages are cited only for listed vial contents, never as evidence of purity or effect.
Drafting used AI assistance under Doserly's editorial rules, followed by source checks and editorial review. It is general education, not medical advice.
Explore the sources
These are the documents cited in this guide. Studies, regulator pages, dosing websites and seller pages answer different questions. Seller pages and lab certificates are cited only for what a label says a vial contains, never as proof of purity or effect. No study has tested this combination in people.
Showing 71 sources
- 01
Unauthorized health products sold online and seized at Rize Fitness may pose serious health risks ↗
Regulatory source
Original page reviewed; lists GLOW 70 mg and KLOW 80 mg with component amounts.
- 02
Beauty Blend (GHK-Cu + KPV) 50 mg/20 mg ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 03
GHK-Cu + KPV "Klow Stack" Peptide Blend 50 mg/10 mg ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 04
Plant-based Exosome Injections for Skin Wound Healing: Experimental Study ↗
Animal study (mixture)
Full text reviewed: 18 rats; the injected mixture listed acetyl octapeptide-3 among about 20 ingredients at an unstated amount.
- 05
The Regenerative Potential of GHK-Cu in Aesthetic Medicine ↗
Systematic review
Original abstract reviewed: 20 studies to March 2026, 18 preclinical and 2 randomized trials.
- 06
FDA Evaluation of KPV-Related Bulk Drug Substances (PCAC briefing) ↗
Regulatory source
Full briefing reviewed.
- 07
SNAP-8: An Anti-Aging Peptide (technical dossier PD017, rev. 3) ↗
Manufacturer dossier (unpublished tests)
Full document reviewed.
Result detail: 17 women, cream with 10% SNAP-8 Solution twice daily for 28 days: average wrinkle-depth change −34.98%, best single result −63.13%; Argireline comparison from a separate 2001 test in 10 women. Not peer reviewed.
- 08
KLOW Blend 80mg ↗
Product label
Product page reviewed for its label: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg per vial.
- 09
Klow (TB500 - 5mg + BPC157 - 5mg + GHK-CU - 50mg) - 60mg/2ml ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 10
Glow Plus (GHK-Cu + TB-500 + BPC-157 + KPV) 50/10/10/10mg ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 11
GLOW 50: GHK-Cu 30mg / BPC-157 10mg / TB500 10mg ↗
Seller product page
Original page reviewed for listed contents; its specifications give the full thymosin beta-4 formula. Not evidence of purity or effect.
- 12
Beauty Blend (GHK-Cu/KPV) 50 mg/20 mg ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 13
GHK-Cu + KPV 50 mg/10 mg vial ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 14
GlowTox: how to use it (GHK-Cu 2% + SNAP-8 0.02% serum) ↗
Seller product and use page
Selected original page sections reviewed; describes practice, not a tested dose.
- 15
KLOW Blend Guide: Dosing, Benefits and Where to Buy ↗
Dosing website
Selected original page sections reviewed, including the skin-flare schedule; describes practice, not a tested dose.
- 16
Peptide-pro complex serum: Investigating effects on aged skin ↗
Human study (uncontrolled)
Full text reviewed. Its reference 17 describes the supplier's 3% split-face test (up to 38%, average 7.1%).
- 17
KPV Peptide Dosage Chart, Protocol & Reconstitution Guide (2026) ↗
Dosing website
Selected original page sections reviewed; describes practice, not a tested dose.
- 18
WADA 2026 Prohibited List ↗
Regulatory source (sport)
Official list checked, including S0 and S2. Sport rules, not clinical evidence.
- 19
GHK-Cu/KPV Peptide Blend (50/20 mg) ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 20
Evaluation of Research Grade Peptides Marketed Directly to Consumers Reveals Extensive Variability ↗
Product-testing analysis (preprint)
Original full text reviewed.
- 21
BPC-157 / TB-500 / KPV / GHK-Cu ("Deadpool Stack") ↗
Dosing website
Original page reviewed for how it uses the Deadpool name; not a tested dose.
- 22
FDA Briefing Document: BPC-157-Related Bulk Drug Substances ↗
Regulatory source
Selected original briefing sections reviewed, including the adverse-event summary.
- 23
GLOW Peptide Blend 30mg ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 24
BPC-157/TB-500/GHK-Cu Glow Blend 10/10/40 mg: certificate of analysis ↗
Lab certificate (seller-submitted)
Original certificate reviewed; one seller-submitted lot, cited for the listed product and analyte naming only.
- 25
GLOW Peptide Blend: GHK-Cu, BPC-157 & TB-500 Explained ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 26
GHK-Cu/KPV Blend 50 mg/20 mg ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 27
Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH ↗
Cell / animal research
Original abstract reviewed. The FDA classes the tested peptide as N-acetylated KPV.
- 28
Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway ↗
Cell / animal research
Original abstract reviewed.
- 29
Unauthorized injectable peptide drugs seized from Optimum Wellness Centre in Calgary, Alberta may pose serious health risks ↗
Regulatory source
Original page reviewed; names GHK-Cu and KPV as separate seized products.
- 30
AURA Blend: GHK-Cu 70 mg, Epithalon 10 mg, SNAP-8 10 mg, KPV 10 mg (100 mg) ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 31
Pro Beauty Blend: GHK-Cu 50 mg, KPV 10 mg, BPC-157 10 mg, TB-500 10 mg, CJC 5 mg, Ipamorelin 5 mg ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 32
GHK-Cu + AHK-Cu: GHK-Cu 50 mg, AHK-Cu 50 mg ↗
Seller product page
Original page reviewed for listed vial contents only; not evidence of purity or effect.
- 33
KLOWS-8 115 mg (KLOW-CU with SNAP-8) ↗
Seller product page
Original page reviewed; it names the product and total weight but not the amount of each peptide. Not evidence of purity or effect.
- 34
Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters ↗
Human study
Full text reviewed by a verification run.
Limitation: concentration undisclosed; active side fixed; company-connected.
- 35
THE EFFICACY OF 2% COPPER PEPTIDE (GHK-Cu) SERUM FOR EYEBROW HYPOTRICHOSIS: A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, SPLIT-FACE COMPARATIVE STUDY ↗
Human study
Full text reviewed by a verification run.
- 36
Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks ↗
Regulatory source
Current official page reviewed.
- 37
Use of KPV tripeptide for dermatological disorders (US20050124551A1) ↗
Patent application
Full text reviewed. Single-person inventor examples, not a trial.
- 38
Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin ↗
Laboratory study (donated human skin)
Original abstract reviewed.
- 39
Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities ↗
Human study (split-face comparison)
Full text reviewed.
Result detail: 0.03% SNAP-8 with 5% ascorbic acid 2-glucoside and 4% cyclic lysophosphatidic acid versus a hyaluronic-acid patch; 21 of 24 completed; funded by the patch maker.
- 40
Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study ↗
Human trial (multi-ingredient gel with GHK-Cu)
Original full text reviewed; company-funded. The product contained GHK-Cu with three other peptides, postbiotics and a plant extract.
- 41
ClinicalTrials.gov search for KPV and related names ↗
Study registry search
Zero studies for KPV; searches for Lys-Pro-Val, lysine-proline-valine and alpha-MSH 11-13 returned only unrelated trials; CZEN 002 and KdPT returned none.
- 42
GHK-Cu Dosing Guide ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 43
GHK-Cu Dosage & Injection Protocol Guide: Reconstitution, Chart & Cycling (2026) ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 44
Snap-8 dosing & administration ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 45
SNAP-8: Dosing & Research Guide ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 46
KLOW Stack Dosage Chart ↗
Dosing website
Selected original page sections reviewed; describes practice, not a tested dose.
- 47
KLOW Stack: GHK-Cu + BPC-157 + TB-500 + KPV (Separate Vials) ↗
Dosing website
Selected original page sections reviewed; describes practice, not a tested dose.
- 48
GHK-CU / Snap-8 topical mixing protocol ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 49
An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin ↗
Human study (uncontrolled)
Full text reviewed.
Result detail: participant-rated redness and flaking rose at week 2, when the serum was first added after a two-week run-in on the supporting regimen; redness persisted to week 10 and cleared by week 14; the investigator found no increase, and the abstract reports no adverse events.
- 50
Facial allergic granulomatous reaction and systemic hypersensitivity associated with microneedle therapy for skin rejuvenation ↗
Case series (not SNAP-8)
Original abstract reviewed: three women with facial granulomas after microneedling with topical products; two had used the same vitamin C serum.
- 51
Granulomatous Reactions From Microneedling: A Systematic Review of the Literature ↗
Systematic review (not SNAP-8)
Original abstract reviewed: 13 studies describing 15 patients; motorized pens and topical vitamin C implicated in most cases.
- 52
PREZATIDE COPPER (GHK-Cu 1:1, copper tripeptide-1): substance record UNII 6BJQ43T1I9 ↗
Substance registry
Record reviewed: formula C14H22N6O4.Cu, 401.91 g/mol. The copper share (about 15.8%) is our arithmetic from these values.
- 53
Copper: Fact Sheet for Health Professionals ↗
Reference fact sheet
Full fact sheet reviewed (archived copy).
- 54
- 55
Role of thymosin beta4 in tumor metastasis and angiogenesis ↗
Cell / animal research
Original abstract reviewed.
- 56
FDA enforcement report D-0051-2026: GHK-Cu (Copper Peptide) for Injection, all strengths ↗
Regulatory source
Enforcement record reviewed: "Lack of Assurance of Sterility".
- 57
July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee ↗
Regulatory source
Original page reviewed.
- 58
Meeting of the Pharmacy Compounding Advisory Committee (GHK-Cu, LL-37, Dihexa acetate, Melanotan II, PEG-MGF) ↗
Regulatory source
Meeting page reviewed: before the end of February 2027; time and location not yet scheduled.
- 59
Safe use of bodybuilding products ↗
Regulatory source
Original page reviewed: says injectable peptides are regulated as prescription drugs and lists KPV and GHK-Cu among peptides sold illegally.
- 60
Think twice before injecting peptides bought online: unauthorized products can seriously harm your health ↗
Regulatory source
Original advisory reviewed; lists BPC-157, TB-500, GHK-Cu and KPV among seized unauthorized injectable peptides.
- 61
Cosmetic Ingredient Hotlist: Prohibited and Restricted Ingredients ↗
Regulatory source
Page reviewed for acetyl octapeptide-3, SNAP-8 and related names: none listed.
- 62
Concerns regarding the public health risks associated with unapproved peptide products ↗
Regulatory source
Media release reviewed (archived copy of 14 Sep 2026): names GHK-Cu among unapproved peptide products; harms are reported for unapproved peptides as a class.
- 63
- 64
Medicines Classification Committee: agenda for the 76th meeting, item 7.4 GHK-Cu (for injection) ↗
Regulatory source
Agenda reviewed: a proposal for the 28 October 2026 meeting, not a decision.
- 65
CosIng ingredient record: ACETYL OCTAPEPTIDE-3 (substance 82188) ↗
Regulatory database
Record reviewed through the official search service: functions humectant and skin conditioning; no annex restriction; status active.
- 66
Peptides, growth hormones and cosmetics ↗
Regulatory source
Page reviewed: lists "Tripeptide-1 (GHK, non-palmitoylated)" among cosmetic peptide ingredients that are not prohibited. Sport guidance, not clinical evidence.
- 67
Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper ↗
Human trial (GHK-Cu gel)
Original abstract reviewed.
- 68
3 months of GHK CU ↗
Community account
Public thread and its comments read in full from an archive copy; usernames removed.
- 69
KPV peptide fixed my eczema ↗
Community account
Post and comments reviewed; used with GHK-Cu after earlier steroid creams.
- 70
Physicochemical characterization of native glycyl-l-histidyl-l-lysine tripeptide for wound healing and anti-aging ↗
Laboratory chemistry study
Original abstract reviewed.
- 71
Specific cleavage of histidine-containing peptides by copper(II) ↗
Laboratory chemistry study
Original abstract reviewed.
No matching sources
Try a different term or show the full list.